'Kick it while it's down' approach to cancer treatment could improve cure rates
Medical Xpress
February 20, 2026
AI-Generated Deep Dive Summary
A new study suggests that optimizing the timing of cancer treatments could significantly improve cure rates. Dr. Robert Noble, a Senior Lecturer at City, University of London, led this research, which focuses on treating cancer when it's least active—a strategy known as "kick it while it's down." This approach aims to target cancer cells during their dormant phase, potentially making treatment more effective.
Current cancer treatments often face challenges due to the varying activity levels of cancer cells. Traditional methods may not account for these fluctuations, leading to reduced effectiveness and increased resistance. Dr. Noble’s study introduces a mathematical model that predicts optimal treatment times based on cancer dormancy patterns, offering a more strategic approach.
By targeting cancer during its inactive state, treatments could avoid fostering drug resistance and enhance overall efficacy. This method could lead to better patient outcomes by maximizing the impact of therapies and minimizing unnecessary exposure to harsh treatments.
This research holds significant promise for patients and healthcare providers alike. Improved treatment timing could mean higher cure rates and fewer side effects, making it a groundbreaking advancement in cancer care. The study’s findings highlight the importance of precision in oncology and open doors for further innovations in personalized treatment plans.
Verticals
healthmedical
Originally published on Medical Xpress on 2/20/2026